Coronavirus / COVID

The therapy demonstrated an efficacy of 65.2% against the Delta variant.

New data suggest countries with limited vaccine supplies may not need to immediately vaccinate all members of low-risk households.

Brain tissue in people who died of SARS-CoV-2 look suspiciously like that of people with various forms of dementia and other neurocognitive conditions.

With millions of people facing long-term COVID-19 conditions, the CDC issued interim guidance on evaluation and care.

The activity was higher than what was recently observed for the South African variant.

94% of the participants in the study developed COVID-19 antibodies.

Unvaccinated healthcare workers showed similar levels of antibodies to vaccinated ones.

COVID-19-associated hospitalization of adolescents is more than 12 times less likely than that of adults, but exceeds that associated with influenza by 2.5 to 3 times, the US Centers for Disease Control and Prevention (CDC) reported.

AFHs reported concerns such as staff coming to work sick and lack of PPE.

IPs experienced PPE shortages, high levels of stress and emotional exhaustion.

The Sinovac developed vaccine generated antibodies against SARS-CoV-2 in a phase 1/2 trial.

The CAD demonstrated excellent sustained antiviral activity against the test pathogen.

Communal gathering areas were found to be a major source of exposure.

During the pandemic, one regional health system looked at the age distribution of the virus and hospitalization and mortality rates.

AstraZeneca’s COVID-19 vaccine was safe and immunogenic for people with HIV who are well-controlled on antiretroviral therapy, a study has shown.

New model uses syndromic surveillance to predict admissions related to SARS-CoV-2.

The therapy is known to exhibit antiviral properties and reduce SARS-CoV-2 replication in laboratory studies.

Seqirus is seeking reactogenicity and immunogenicity outcomes between its influenza vaccines and available mRNA vaccines for COVID-19.

Plus: how could the COVID-19 testing market boom improve public flu awareness?

Recommendations based on local pollen levels may help manage infection risk.

As many vaccines are under Emergency Use Authorization (EUA), understanding the incidence rates of adverse events is critical to providing education and awareness, while working to increase distribution.

COVID-19 response restrained flu outbreaks last year. An expert explains his concern that won't be enough this winter.

A preview of our August 2021 issue Chairman’s Letter.

Delta Plus is very similar to the Delta variant with 1 additional mutation.

With a small number of heart-related adverse effects in younger people, the US Food and Drug Administration (FDA) will move towards a warning statement for Pfizer and Moderna vaccines.